You are not eligible to view 4 messages. To gain access to more recent message posts signup free for membership.
#
AUTHOR
DATE
SUBJECT
6
member
4/14/17 4:38PM
Bear Case
How do you get comfortable with the terminal values of Copaxone and their generics business? Their lifecycle management of Copaxone has been truly incredible, but it appears like the jig may be up. Similarly, US generics... login to read the rest
Taro basically provides no guidance and little look through but has a rock solid balance sheet and a likely takeover and is still very cheap despite the declining earnings. Plus it focuses on smaller dollar
The consensus estimates I'm looking at have TEVA revenue more or less flat over the next two years, and EPS up slightly. TARO estimates have revenue declining 15%, and EPS down 25% (from $11.00/shr to... login to read the rest
Are you sure you want to close this position TEVA PHARMACEUTICALS (TEVA)?
By closing position, I’m notifying VIC Members that at today’s market price, I no longer am recommending this position.
Flag TEVA PHARMACEUTICALS (TEVA) for Removal
Are you sure you want to Flag this idea TEVA PHARMACEUTICALS (TEVA) for removal?
Flagging an idea indicates that the idea does not meet the standards of the club and you believe it should be removed from the site. Once a threshold has been reached the idea will be removed.
You Cannot Submit Message ... Yet
You currently do not have message posting privilages, there are
1 way you can get the privilage.
You can apply for full membership by submitting an investment idea of your own. Or if you are in reactivation status, you need to reactivate your full membership.